Dicerna Financial Statements From 2010 to 2025
Dicerna Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Dicerna Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Dicerna Pharmaceuticals financial statements helps investors assess Dicerna Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Dicerna Pharmaceuticals' valuation are summarized below:Dicerna Pharmaceuticals does not presently have any fundamental signals for analysis.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Check Dicerna Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dicerna Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Dicerna financial statements analysis is a perfect complement when working with Dicerna Pharmaceuticals Valuation or Volatility modules.
Dicerna |
Dicerna Pharmaceuticals Company Operating Margin Analysis
Dicerna Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Dicerna Pharmaceuticals Operating Margin | (62.88) % |
Most of Dicerna Pharmaceuticals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dicerna Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Dicerna Pharmaceuticals has an Operating Margin of -62.88%. This is 79.25% higher than that of the Healthcare sector and 43.89% lower than that of the Biotechnology industry. The operating margin for all United States stocks is notably higher than that of the company.
Dicerna Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dicerna Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Dicerna Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dicerna Pharmaceuticals competition to find correlations between indicators driving Dicerna Pharmaceuticals's intrinsic value. More Info.Dicerna Pharmaceuticals is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dicerna Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Dicerna Stock
If you are still planning to invest in Dicerna Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dicerna Pharmaceuticals' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |